• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106015
Device Problems Mechanical Problem (1384); Infusion or Flow Problem (2964); Noise, Audible (3273)
Patient Problems No Consequences Or Impact To Patient (2199); Insufficient Information (4580)
Event Date 12/27/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
It was reported that the patient had high flow and high power events on (b)(6) 2020 and heard grinding from the pump.The patient was admitted for low inr.Upon review of the log files, there were no unusual events noted.
 
Event Description
It was reported that the patient underwent a pump exchange on (b)(6) 2021, hmii (b)(6), to hmii (b)(6).
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is complete.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: elevated power and flow events were confirmed in the evaluation of the submitted controller event log file; however, a specific cause for the events cannot be determined through this evaluation.A specific cause for the reported grinding noise coming from the pump could not conclusively be determined through this evaluation.The submitted log file contained data from (b)(6) 2020 14:53:05 through (b)(6) 2020 00:29:17.Two elevated power events of 9.1 and 11.4 watts were captured on (b)(6) 2020, and estimated flow reached 11.0 and 12.0 lpm during these events.These events were captured while the patient was supported by battery power.Prior to and after the elevated flow and power events, the pump appeared to function as intended and no other unusual alarms or events were captured.A specific cause for the changes in pump parameters could not be conclusively determined through this evaluation.Per the customer, the patient¿s lvad parameters were being monitored.The grinding had since stopped but continued to monitor.The patient was asymptomatic, stable, and remains on routine care.It was reported through patient product that the patient underwent pump exchange on (b)(6) 2021, hmii (b)(6) to hmii (b)(6).(b)(6) was not returned for evaluation.The patient remains ongoing on heartmate ii left ventricular assist system (lvas), serial number (b)(6).No product is available for investigation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The lvas kit shipped on 09may2016.The heartmate ii lvas instructions for use (ifu) provides an explanation of each of the pump parameters (including pump power and flow) in sections 1 "introduction" and 4 "system monitor".Section 1 (under "explanation of parameters") explains that device power is a direct measurement of pump motor voltage and current.Changes in pump speed, flow, or physiological demand can affect pump power.Abrupt changes in power should be evaluated for cause.In addition, device flow and power generally retain a linear relationship at a given speed.However, while power is directly measured by the system controller, the reported flow is estimated, based on power.Since the flow displayed on the system controller is a calculated value, it becomes imprecise at the low and high ends of the linear power-flow relationship.Section 4 ¿system monitor¿ cautions that no single parameter is a surrogate for monitoring the clinical status of the patient, and the changes in all parameters should be considered when assessing any clinical situation.Section 4 also addresses pi events as well as potential causes.Section 6 "patient care and management" (under "pump performance monitoring") addresses assessing pump flow and explains that pump performance is sensitive to changes in systemic vascular resistance and left ventricular filling.Heartmate ii lvas patient handbook, is currently available.Section 1 ¿introduction¿ directs the user to call a hospital contact right away ¿if you notice a change in how your pump sounds, feels, or works.Even small changes should be reported.¿ no further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS)
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key11180290
MDR Text Key227563541
Report Number2916596-2020-06562
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024011224
UDI-Public00813024011224
Combination Product (y/n)N
PMA/PMN Number
P060040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 03/29/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/15/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/31/2019
Device Model Number106015
Device Catalogue Number106015
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received03/24/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age27 YR
Patient Weight123
-
-